Gait, Hemiplegic
Conditions
Keywords
hemiplegic gait, peroneal nerve stimulation, gait analysis
Brief summary
The aim of this study is to investigate the effects of the implantable drop foot stimulator ActiGait (Ottobock Health Care, Duderstadt, Germany) on gait in hemiparetic patients. While several studies investigated the effects of implanted systems on walking speed and gait endurance, only a few studies have focused on the system's impact on kinematics and long-term outcomes. Therefore, our aim was to further investigate the effects of the implanted system ActiGait on gait kinematics and spatiotemporal parameters with a 1-year follow-up period.
Detailed description
Patients with a neurologic condition leading to drop foot during swing phase in gait are treated by the implentation of the AcitGait system (which has a CE-certificate in Europe). The aim of this study is to investigate the effect of the device on gait with a follow-up period of one year. Patients are assessed before implantation and at one-year follow up. At baseline, they are asked to walk without any assistive device, as well as with surface electrical stimulation of the peroneal nerve. At follow-up, they are asked to walk with the ActiGait system switched off and switched on. Outcome assessments include a 10m-walking test and gait analysis with a VICON 3D-camera system. This allows to extract spatio-temporal parameters (as steps per minute, step length,...) as well as kinematic data (e.g. joint ankles during the gait cycle). All outcome data is analyzed using statistical tests.
Interventions
DEVICEActiGait
implanted device for peroneal nerve stimulation
Sponsors
Medical University of Vienna
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
patients meeting the inclusion criteria are included
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* drop foot after stroke, brain haemorrhage or multiple sclerosis * a minimum of six months after the acute infarction/onset of the disease * passive extension of the ankle to at least at neutral position * no sufficient active ankle extension * free walking without any aid for at least 20 meters in less than 2 minutes * a walking speed of ≤ 1,2m/sec (measured with 10 meter walking test) * use of surface electrical stimulation for at least three months * be able to stand freely
Exclusion criteria
* damage to the peripheral nervous system * epilepsy * adiposity * substance abuse * no cognitive ability to follow the study instructions * pregnancy * use of other implanted devices * instable ankle joint or fixed contracture
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| kinematic gait parameters | 1 year | Kinematic gait parameters are recorded and analysed using a 3D VICON infra-red camera system. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| spatio-temporal parameters | 1 year | Spatio-temproal parameters are recorded and analysed using a 3D VICON infra-red camera system. |
| 10-m-walking test | 1 year | The 10-m-walking test is a standardised clinical test where the patient is asked to walk for 10m at the fastest convenient walking speed and time is taken. |
| Visual Analogue Scale for Health | 1 year | Using a 100mm Visual Analogue Scale (VAS) patients are asked to mark their current health status between 0 (worst possible health) and 100 (best possible health). |
Outcome results
None listed